NCT00285441

Brief Summary

The purpose of this study is to identify differences in TB specific immune responses among immunosuppressed patients latently infected with TB and patients with active TB.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2005

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2005

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 31, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 2, 2006

Completed
2.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2008

Completed
Last Updated

February 28, 2006

Status Verified

December 1, 2005

First QC Date

January 31, 2006

Last Update Submit

February 27, 2006

Conditions

TuberculosisHIV InfectionsRheumatoid Arthritis

Keywords

HIV

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Latent TB infection + rheumatid arthritis
  • Latent TB infection + HIV
  • Active TB

You may not qualify if:

  • Age \< 18yrs
  • Pregnancy
  • Patients not able to understand the given information

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Infectious disease department University Hospital Hvidovre

Copenhagen, 2650, Denmark

RECRUITING

Related Links

MeSH Terms

Conditions

TuberculosisHIV InfectionsArthritis, Rheumatoid

Condition Hierarchy (Ancestors)

Mycobacterium InfectionsActinomycetales InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsBlood-Borne InfectionsCommunicable DiseasesSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune Diseases

Study Officials

  • Morten Ruhwald, MD

    University Hospital Hvidovre

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Morten Ruhwald, MD

CONTACT

+45 36323632mruhwald@mail.dk

Pernille Ravn, MD, Ph.d.

CONTACT

+45 36323632pravn@dadlnet.dk

Study Design

Study Type
observational
Observational Model
DEFINED POPULATION
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 31, 2006

First Posted

February 2, 2006

Study Start

November 1, 2005

Study Completion

September 1, 2008

Last Updated

February 28, 2006

Record last verified: 2005-12

Locations

DK(1)